EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey

Kento Ikegawa, Masanobu Fujimoto, Kohei Aoyama, Hirofumi Nakayama, Takuo Kubota, Keisuke Nagasaki, Setsuko Naganuma, Makoto Ono, Shinji Higuchi, Haruo Mizuno, Susumu Kanzaki, Yoshihiko Morikawa und 3 weitere

Endocrine Journal · 2026

DOI: 10.1507/endocrj.ej25-0431 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endocrine Journal, 2026. Verfasst von Kento Ikegawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Deamino Arginine Vasopressin, Diabetes Insipidus, Nephrogenic, Antidiuretic Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deamino Arginine VasopressinDiabetes Insipidus, NephrogenicAntidiuretic AgentsHumansRetrospective StudiesFemaleMaleChild, PreschoolChildTreatment OutcomeJapanInfantOsmolar ConcentrationReceptors, Vasopressin

Stichwörter der Autor:innen

1-deamino-8-D-arginine vasopressinArginine vasopressin resistanceChildrenCongenital nephrogenic diabetes insipidusDesmopressin

Substanzen

Deamino Arginine VasopressinAntidiuretic AgentsReceptors, Vasopressin

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
  • Division of Pediatrics and Perinatology, Faculty of Medicine, Tottori University, Tottori, Japan.
  • Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
  • Department of Pediatrics, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
  • Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Zitieren

APA

Ikegawa, K., Fujimoto, M., Aoyama, K., Nakayama, H., Kubota, T., Nagasaki, K., Naganuma, S., Ono, M., Higuchi, S., Mizuno, H., Kanzaki, S., Morikawa, Y., Honda, M., Amano, N., & Hasegawa, Y. (2026). Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0431

Vancouver

Ikegawa K, Fujimoto M, Aoyama K, Nakayama H, Kubota T, Nagasaki K, et al. Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey. Endocrine Journal. 2026. doi:10.1507/endocrj.ej25-0431

BibTeX
@article{Ikegawa2026,
  author = {Ikegawa, Kento and Fujimoto, Masanobu and Aoyama, Kohei and Nakayama, Hirofumi and Kubota, Takuo and Nagasaki, Keisuke and Naganuma, Setsuko and Ono, Makoto and Higuchi, Shinji and Mizuno, Haruo and Kanzaki, Susumu and Morikawa, Yoshihiko and Honda, Masataka and Amano, Naoko and Hasegawa, Yukihiro},
  title = {Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey},
  journal = {Endocrine Journal},
  year = {2026},
  doi = {10.1507/endocrj.ej25-0431}
}
Kostenlos starten →